A detailed history of Sage Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sage Capital Management, LLC holds 472 shares of VRTX stock, worth $237,156. This represents 0.11% of its overall portfolio holdings.

Number of Shares
472
Previous 472 -0.0%
Holding current value
$237,156
Previous $221 Million 0.78%
% of portfolio
0.11%
Previous 0.12%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$392.81 - $485.53 $185,406 - $229,170
472 New
472 $221 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sage Capital Management, LLC Portfolio

Follow Sage Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Management, LLC with notifications on news.